1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,107 | 0,147 | 07:47 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.07. | hVIVO PLC - Proposed appointment of Chair | - | RNS | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 22.07. | TRADING UPDATES & EARNINGS: hVIVO expects interim revenue decline | 1 | Alliance News | ||
| 22.07. | hVIVO PLC - H1 Trading update | - | RNS | ||
| 18.07. | hVIVO PLC - Directorate Change | - | RNS | ||
| 09.07. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
| 30.06. | hVivo reports positive results from its largest lab contract to date | 1 | Sharecast | ||
| 30.06. | hVIVO reports positive results from Cidara's Phase 2b influenza study | 3 | Investing.com | ||
| 30.06. | hVIVO PLC - Positive results from client Phase 2b field study | - | RNS | ||
| 05.06. | hVIVO PLC - Result of AGM | - | RNS | ||
| 02.06. | DIRECTOR DEALINGS: hVIVO CEO buys shares; Investec execs sell stock | 2 | Alliance News | ||
| 02.06. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
| 30.05. | hVIVO stock plunges after contract cancellations in 'depressed' market | 1 | Alliance News | ||
| 30.05. | Hvivo shares tank after contract cancellations | 4 | Shares | ||
| 30.05. | AIM WINNERS & LOSERS: hVIVO shares dive on contract cancellations | 1 | Alliance News | ||
| 30.05. | Hvivo client cancels 'significant' HCT trial contract | 1 | Sharecast | ||
| 30.05. | hVIVO PLC - Trading update | - | RNS | ||
| 29.05. | hVIVO PLC - Appointment of Independent Non-Executive Director | - | RNS | ||
| 12.05. | hVIVO announces annual report and upcoming AGM | 1 | Investing.com | ||
| 12.05. | hVIVO kündigt Jahresbericht und kommende Hauptversammlung an | 1 | Investing.com Deutsch | ||
| 12.05. | hVIVO PLC - Annual Report, Notice of AGM & Directorate Change | - | RNS |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,728 | 0,00 % | Plus Therapeutics files to sell 33M shares of common stock for holders | ||
| LIFEWARD | 0,698 | 0,00 % | Lifeward Ltd.: Lifeward to Report Second Quarter Financial Results on August 14, 2025 | ||
| JD HEALTH | 6,000 | +0,84 % | HSI Up 470 pts; HSTI Up 127 pts; BABA Up over 4%; MEITUAN Up over 3%; TENCENT Up over 3%; TENCENT, WH GROUP, JD HEALTH, AIA, ZIJIN MINING Hit New Highs | ||
| EKSO BIONICS | 2,910 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 5,990 | +1,53 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.08.2025 | Das Instrument 9YG NO0010955917 DEEP VAL.DRILL.AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.08.2025 und ex Kapitalmassnahme am 07.08.2025 The instrument 9YG NO0010955917 DEEP VAL.DRILL.AS... ► Artikel lesen | |
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 0,853 | +2,03 % | Rockwell Medical signs multi-year supply agreement with Innovative Renal Care | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| VIRIDIAN THERAPEUTICS | 14,335 | 0,00 % | These Analysts Revise Their Forecasts On Viridian Therapeutics Following Q2 Results | ||
| SINTX TECHNOLOGIES | 3,010 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors | New leadership and recapitalization to accelerate commercialization of proprietary silicon nitride technologies in medical and high-growth markets SALT LAKE CITY, Utah, June 12, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| AETHLON MEDICAL | 1,430 | -100,00 % | Preview: Aethlon Medical's Earnings | ||
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | Stagezero Life Sciences Ltd (2): Stagezero to delist from TSX, applies for NEX listing | ||
| NEURONETICS | 3,355 | +1,82 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| SAVARIA | 13,100 | -0,76 % | Savaria Corporation: Record Quarter as Savaria Delivers $16.3M of Net Earnings and Reaches 20.6% Adjusted EBITDA Margin in Q2 2025 | LAVAL, Quebec, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Savaria Corporation ("Savaria") (TSX: SIS), one of the global leaders in the accessibility industry, is pleased to announce its results for the second... ► Artikel lesen |
HVIVO PLC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,107 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.